Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Filing Details

Accession Number:
0001104659-15-013152
Form Type:
4
Zero Holdings:
No
Publication Time:
2015-02-23 21:48:30
Reporting Period:
2015-02-19
Filing Date:
2015-02-23
Accepted Time:
2015-02-23 21:48:30
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1600132 Bellerophon Therapeutics Inc. BLPH Pharmaceutical Preparations (2834) 473116175
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1219039 Keith Crandell 8725 West Higgins Road, Suite 290
Chicago IL 60631
No No Yes No
1219043 Clinton Bybee 8725 West Higgins Road, Suite 290
Chicago IL 60631
No No Yes No
1222135 Arch Venture Fund Vi Lp 8725 West Higgins Road, Suite 290
Chicago IL 60631
No No Yes No
1274410 Arch Venture Partners Vi Lp 8725 West Higgins Road, Suite 290
Chicago IL 60631
No No Yes No
1274412 Arch Venture Partners Vi Llc 8725 West Higgins Road, Suite 290
Chicago IL 60631
No No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2015-02-19 212,666 $12.00 965,660 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Footnotes
  1. ARCH Venture Partners VI, L.P. (the "GPLP"), as the sole general partner of ARCH Venture Fund VI, L.P. ("ARCH"), may be deemed to beneficially own certain of the shares held by ARCH. The GPLP disclaims beneficial ownership of all shares held by ARCH in which the GPLP does not have an actual pecuniary interest. ARCH Venture Partners VI, LLC (the "GPLLC"), as the sole general partner of the GPLP, may be deemed to beneficially own certain of the shares held by ARCH.
  2. The GPLLC disclaims beneficial ownership of all shares held by ARCH in which it does not have an actual pecuniary interest. The managing directors of the GPLLC, Robert T. Nelsen, Keith Crandell and Clinton Bybee (together, the "Managing Directors"), are deemed to have voting and dispositive power over the shares held by ARCH, and may be deemed to beneficially own certain of the shares held by ARCH. The Managing Directors disclaim beneficial ownership of all shares held by ARCH in which they do not have an actual pecuniary interest.